MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Clinical trials for MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE trials appear
Sign up with your email to follow new studies for MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an old allergy drug fix nerve damage in MS?
Disease control Recruiting nowThis study tests whether clemastine fumarate, an allergy medicine, can help repair the protective coating (myelin) around nerve cells in people with multiple sclerosis (MS). About 74 adults with relapsing-remitting MS will receive either the drug or a placebo, and advanced MRI sc…
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Immune cell overhaul: could CAR t therapy halt progressive MS?
Disease control Recruiting nowThis early-phase study tests a new treatment called KYV-101 for people with progressive forms of multiple sclerosis (MS) that are not responding to standard therapies. The treatment uses a patient's own immune cells, modified to target and remove faulty immune cells that may driv…
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
AI-Powered study aims to unlock secrets of multiple sclerosis progression
Knowledge-focused Recruiting nowThis study is collecting health data from 100 people with multiple sclerosis (MS) to find new ways to track the disease using artificial intelligence. Researchers will look at medical images, blood tests, and smartphone data to better understand how MS changes over time. The goal…
Matched conditions: MULTIPLE SCLEROSIS, PRIMARY PROGRESSIVE
Sponsor: University Hospital, Basel, Switzerland • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC